Curcumin dispersed with colloidal nano-particles inhibits enteric viruses replication

Area of Science:

• Virology
• Nanotechnology
• Pharmacology

Background:

• Acute gastroenteritis is a prevalent global health issue with limited antiviral treatment options.
• Viral diarrhea, a common cause of gastroenteritis, necessitates the development of effective therapies.
• A novel, highly bioavailable nano-dispersed curcumin formulation has recently been developed.

Purpose of the Study:

• To evaluate the in vitro antiviral efficacy of a nano-dispersed curcumin formulation.
• To determine the potential of this curcumin formulation as a broad-spectrum antiviral agent against gastrointestinal viruses.

Main Methods:

• In vitro testing of nano-dispersed curcumin against astrovirus, norovirus, rotavirus, adenovirus, echovirus, and coxsackievirus.
• Assessment of viral replication inhibition.
• Evaluation of curcumin formulation's biocompatibility and bioavailability.

Main Results:

• The nano-dispersed curcumin formulation demonstrated significant inhibition of replication for all tested gastrointestinal viruses.
• The formulation was well-tolerated by cells in culture.
• Rapid absorption into blood plasma was observed after oral administration in preliminary assessments.

Conclusions:

• The tested nano-dispersed curcumin formulation exhibits promising broad-spectrum antiviral activity against key gastrointestinal viruses.
• This bioavailable curcumin derivative represents a potential candidate for developing novel antiviral treatments for viral diarrhea.